ロード中...
Seatbelts in CAR therapy: How Safe Are CARS?
T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491658/ https://ncbi.nlm.nih.gov/pubmed/26110321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8020230 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|